Aidian is a Finnish-based in vitro diagnostics (IVD) company that develops, manufactures, and distributes diagnostic tests for point-of-care use. The company's core business is focused on providing reliable and fast CE-marked diagnostic tests, particularly for primary care settings. Aidian's product portfolio includes solutions for infectious disease diagnostics, diabetes management, colorectal cancer screening, and hygiene monitoring. Their flagship product, QuikRead go Plus, is a point-of-care testing instrument that delivers accurate results in minutes, supporting healthcare professionals in making fast and reliable diagnoses. The company aims to aid global health by promoting efficient healthcare through accurate and fast diagnostics, with a special focus on combating antimicrobial resistance (AMR) by optimizing antibiotic use.

Aidian, formerly Orion Diagnostica, is a Finnish-based IVD company with almost 50 years of experience in developing and manufacturing reliable, fast and easy-to-use diagnostic tests especially for primary care.

We offer our customers and partners the best solutions and service with a customer-focused mindset, high-quality products and agile operations. With a strong can-do attitude we aim to provide flexible solutions to our customers’ specific needs.

We have 300 dedicated employees who want to be in the forefront of creating tools for better healthcare. One correct treatment decision at a time, we help tackle one of the biggest threats to global health, antimicrobial resistance.

In addition to our Head Quarters in Espoo Finland, we have local offices in 12 different countries: Sweden, Norway, Denmark, Germany, Czech Republic, Slovakia, Hungary, Poland, the Netherlands, Belgium, Estonia and China.

We are more focused than ever in expanding our company and developing products that meet the demands of our customers now and in the future.

Our global footprint covers over 60 countries. Our QuikRead go® flagship products are used globally, with close to 60,000 instruments in use by our customers. We are fully compliant with the ISO 13485 Quality Standard as well as FDA requirements.

Point of care
Microbiology
Molecular diagnostics
Hygiene monitoring
RIA / Collagens
Respiratory tract infections
COVID-19

1974